The Capillary Failure Hypothesis
A network can fail without stopping
An organ may continue receiving blood even when its exchange network becomes inefficient. The total flow through an organ may conceal nonuniform capillary transit times, local loss of perfused channels or longer effective diffusion distances. The key property is not simply vessel count but the number and spatial arrangement of vessels currently capable of exchanging oxygen and solutes. In critical illness this 'functional capillary density' has been studied directly and is relevant to the problem of tissue oxygenation.
Several roads toward the same phenotype
Small-vessel obstruction, endothelial swelling, leukocyte plugging, abnormal vascular tone and structural rarefaction can each reduce effective exchange. Their causes and timescales differ. Sepsis may produce rapid flow heterogeneity; hypertension and diabetes can produce chronic microvascular changes; an embolic occlusion has an altogether different mechanism. A capillary-failure hypothesis is clinically useful only if it specifies which mechanism is suspected in which disorder.
Why a single blood test is inadequate
No routine plasma analyte reveals the full topology of a capillary network. This is one reason systemic markers can diverge from tissue function. But it is also a reason to avoid claiming unseen capillary failure when data are absent. Imaging, tissue oxygen measurements and disease-specific physiological assessments may provide partial views, and each has validity and feasibility limits. Negative peripheral tests do not prove an inaccessible tissue is normal, but neither do they establish disease by inference.
Proposed explanatory value
The hypothesis predicts that in some patient groups, measures of microvascular function will account for outcome differences after conventional variables—blood pressure, arterial oxygen content, macrovascular patency and disease severity—have been considered. If the relationship is causal, improving the microvascular defect should improve organ-level outcomes. The hardest question is whether changes in capillary measures are drivers of recovery or simply readouts of another successful intervention.
When the hypothesis should not be used
This is not a warrant to treat every patient with fatigue, fogginess or dizziness as having microvascular disease. Symptoms can arise from sleep disorders, medications, endocrine conditions, psychiatric illness, neurologic lesions, deconditioning and many other causes. The value of capillary thinking is that it offers a concrete physiological question worth pursuing when warranted, not a catch-all explanation.
A distinction between perfusion and exchange
Blood flow and exchange are related but not identical. Flow through a large vessel can be measured or estimated without revealing whether every capillary is contributing. At the microscopic level, red-cell transit time, capillary hematocrit, diffusion distance and tissue demand jointly shape the capacity to deliver oxygen. The functional density concept directs attention to perfused vessels rather than simply anatomical counts. It is especially helpful in understanding why a macrovascular measurement may not explain severe organ dysfunction.
Disease-specific hypotheses are stronger than universal theories
For septic shock, altered microvascular flow has a direct mechanistic and clinical research tradition. For diabetic microangiopathy, structural capillary and basement-membrane changes are relevant over longer periods. For chronic fatigue syndromes, hypotheses about microvascular contributions require carefully separated cohorts, validated measurement and comparison with autonomic, immunological and metabolic alternatives. It would be misleading to cite sepsis research as though it were direct evidence for unrelated chronic conditions.
The falsifying comparison
A valuable study would ask whether capillary measures add predictive information once systemic pressure, arterial oxygen content, disease burden and medication effects have been included. If they fail, the explanatory increment is small. A second question asks whether treatments altering microvascular function improve organ outcomes. The distinction between an informative marker and a modifiable driver is essential. Not every measurable abnormality should become a therapeutic target.
Selected scientific reading
- Ellis CG, Jagger J, Sharpe M. The microcirculation as a functional system. Crit Care. 2005;9(Suppl 4):S3–S8.
- Østergaard L et al. Microcirculatory dysfunction and tissue oxygenation in critical illness. Acta Anaesthesiol Scand. 2015;59:1246–1259.
- Ince C. The microcirculation is the motor of sepsis. Crit Care. 2005;9(Suppl 4):S13–S19.